http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
MDxHealth Announces Growth Investment from MVM Partners
-
MDxHealth to Receive $2.3 million “Paycheck Protection Program” Loan Under the U.S. CARES Act
-
MDxHealth Provides Q1-2020 Business Update
-
MDxHealth Reports Financial Year 2019 Results and Provides Outlook for 2020
-
MDxHealth Provides Q3-2019 Business Update
-
MDxHealth Shareholder Transparency Declaration
-
MDxHealth's New Share Capital Amount and New Number of Shares
-
MDxHealth Shareholder Transparency Declaration
-
MDxHealth Reports Half Year 2019 Financial Results and Strategic Update
-
MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Test
-
MDxHealth (R): MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx Test
-
MDxHealth: MDxHealth Notice of Interim Results 2019
-
MDxHealth (R): Extraordinary General Shareholders’ Meeting
-
MDxHealth (R): Annual General Shareholders’ Meeting
-
MDxHealth Announces Presentation of Positive Data for ConfirmMDx and SelectMDx in Prostate Cancer Diagnosis
-
MDxHealth provides Q1 2019 business update
-
MDxHealth (R): MDxHealth provides Q1 2019 business update
-
MDxHealth (R): MDxHealth Announces Positive Data from Pan-European Clinical Validation Study of SelectMDx
-
MDxHealth Announces Positive Data from Pan-European Clinical Validation Study of SelectMDx
-
MDxHealth : SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in the 2019 Italian Society of Urology Guidelines
-
MDxHealth Reports Financial Year 2018 Results and Provides Outlook for 2019
-
MDxHealth (R): MDxHealth Reports Financial Year 2018 Results and Provides Outlook for 2019
-
MDxHealth (R): MDxHealth Appoints Michael K. McGarrity as CEO
-
MDxHealth (R): MDxHealth Announces Presentation of Positive Data for SelectMDx and ConfirmMDx in Prostate Cancer Diagnosis
-
MDxHealth Signs Partnership with LifeLabs to Make SelectMDx Available in Canada
-
MDxHealth (R): MDxHealth Signs Partnership with LifeLabs to Make SelectMDx available in Canada
-
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
-
MDxHealth (R): SelectMDx Outperforms Prostate Health Index (phi) Blood Test for Detecting High-Grade Prostate Cancer
-
MDxHealth (R): MDxHealth Provides Business Update
-
MDxHealth Announces Approval for SelectMDx for Prostate Cancer by New York State
-
MDxHealth (R): MDxHealth Announces Approval for SelectMDx for Prostate Cancer by New York State
-
SelectMDx improves prostate biopsy decision-making in urology practices
-
MDxHealth (R): SelectMDx improves prostate biopsy decision-making in urology practices
-
MDxHealth Provides Business Update for the first nine months of 2018
-
MDxHealth Shareholder Transparency Declaration MDxHealth (R):
-
MDxHealth Reports Half Year 2018 Results
-
MDxHealth (R): MDxHealth Reports Half Year 2018 Results
-
MDxHealth (R): SelectMDx Cost-effective in Four European Countries
-
MDxHealth (R): SelectMDx Cost-effective in Four European Countries
-
MDxHealth (R) : MDxHealth Notice of Interim Results 2018
-
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
-
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
-
MDxHealth: SelectMDx Study Demonstrates Cost-effectiveness in US Healthcare System
-
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
-
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
-
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
-
MDxHealth launch agreement with Philips for prognostic prostate cancer biomarker
-
Annual General Shareholders' Meeting
-
MDxHealth (R): Presentation of New Data on MDxHealth's Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting
-
MDxHealth releases 2017 Annual Report

